Clinical Trial Update: Phase III Adaptive Adaptive Stereostactic Body Radiotherapy (SBRT) With Dose Escalation for High-Risk Prostate Cancer [NA]

View source ↗

Summary

An update on a Phase III adaptive SBRT trial with dose escalation for high-risk prostate cancer, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Center Eugene Marquis | Conditions: High Risk Prostate Cancer | NA | Status: RECRUITING